282.13
Veeva Systems Inc stock is traded at $282.13, with a volume of 6.41M.
It is up +15.20% in the last 24 hours and up +45.08% over the past month.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
See More
Previous Close:
$244.91
Open:
$275.355
24h Volume:
6.41M
Relative Volume:
2.90
Market Cap:
$45.83B
Revenue:
$3.32B
Net Income/Loss:
$941.65M
P/E Ratio:
50.24
EPS:
5.6161
Net Cash Flow:
$1.64B
1W Performance:
+12.61%
1M Performance:
+45.08%
6M Performance:
+55.01%
1Y Performance:
-3.90%
Veeva Systems Inc Stock (VEEV) Company Profile
Name
Veeva Systems Inc
Sector
Industry
Phone
925-452-6500
Address
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV vs TEM, BTSG, TXG, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
VEEV
Veeva Systems Inc
|
282.13 | 40.70B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
70.69 | 12.03B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
60.90 | 11.78B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TXG
10 X Genomics Inc
|
64.85 | 8.32B | 638.78M | -22.66M | 122.18M | -0.1744 |
|
HQY
Healthequity Inc
|
93.39 | 8.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Downgrade | Citigroup | Buy → Neutral |
| Feb-17-26 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-26 | Resumed | Goldman | Sell |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-12-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-07-25 | Upgrade | TD Cowen | Hold → Buy |
| Sep-08-25 | Upgrade | JP Morgan | Neutral → Overweight |
| May-29-25 | Reiterated | Needham | Buy |
| Jan-23-25 | Downgrade | Goldman | Buy → Sell |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-19-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Initiated | Exane BNP Paribas | Outperform |
| Aug-27-24 | Reiterated | Citigroup | Buy |
| Jul-09-24 | Initiated | BTIG Research | Buy |
| Oct-25-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-13-23 | Initiated | Jefferies | Buy |
| Jun-28-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-01-23 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-17-23 | Downgrade | Truist | Buy → Hold |
| Feb-23-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-04-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-06-22 | Initiated | Cowen | Market Perform |
| Dec-02-22 | Reiterated | Needham | Buy |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-19-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-27-22 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | Goldman | Buy |
| Jun-21-22 | Resumed | Guggenheim | Buy |
| Mar-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-28-22 | Initiated | Truist | Buy |
| Jan-07-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-06-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Resumed | Stifel | Buy |
| Sep-02-21 | Reiterated | BofA Securities | Buy |
| Sep-02-21 | Reiterated | JMP Securities | Mkt Outperform |
| Sep-02-21 | Reiterated | Needham | Buy |
| Sep-02-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Initiated | Cowen | Outperform |
| Mar-31-21 | Upgrade | UBS | Sell → Neutral |
| Jan-07-21 | Resumed | KeyBanc Capital Markets | Overweight |
| Dec-09-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-14-20 | Resumed | UBS | Sell |
| Aug-28-20 | Reiterated | Needham | Buy |
| Jul-23-20 | Initiated | FBN Securities | Outperform |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Jun-08-20 | Initiated | Citigroup | Buy |
| May-29-20 | Reiterated | Needham | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-19-20 | Initiated | Robert W. Baird | Outperform |
| Feb-14-20 | Initiated | Piper Sandler | Overweight |
| Jan-13-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-27-19 | Reiterated | Canaccord Genuity | Hold |
| Sep-26-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-28-19 | Reiterated | Needham | Buy |
| Jun-07-19 | Initiated | Goldman | Neutral |
| May-30-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | Stephens | Equal-Weight → Overweight |
| May-24-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-27-19 | Reiterated | Needham | Buy |
View All
Veeva Systems Inc Stock (VEEV) Latest News
Veeva Systems (VEEV) Names Dan Rizzo EVP Of Sales Consulting And Services - Yahoo Finance UK
From Service as an Afterthought to Agentic Service for HCPs - Veeva
Veeva (VEEV) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
Veeva Systems Q2 2027 Earnings Preview — August 26; Street Expects $2.22 EPS - AlphaStreet
Veeva Systems (VEEV) Receives a Buy from Guggenheim - The Globe and Mail
Veeva Systems (VEEV) Announces Leadership Transition as Dan Rizz - GuruFocus
Veeva Systems names Dan Rizzo EVP of sales amid leadership change - StreetInsider
Veeva Systems Inc. Announces Management Changes, Effective October 2, 2026 - marketscreener.com
Guggenheim raises Veeva Systems stock price target on billings outlook By Investing.com - Investing.com Canada
Guggenheim Adjusts Price Target on Veeva Systems to $276 From $232, Maintains Buy Rating - marketscreener.com
Veeva Systems Inc (VEEV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
How Eli Lilly’s Global Vault CRM Rollout At Veeva Systems (VEEV) Has Changed Its Investment Story - simplywall.st
Is It Too Late to Buy Veeva Systems Inc (VEEV) After 3.4% Rally? GF Value Says Undervalued - GuruFocus
Do Wall Street Analysts Like Veeva Systems Stock? - inkl
Plato Investment Management Ltd Buys New Shares in Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems (VEEV) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
VEEV (Veeva Systems) 12-1 Month Momentum % : -30.74% (As of Aug. 19, 2026) - GuruFocus
3 Insights on HCO Hierarchies From Top Pharma Leaders | Veeva - Veeva
Veeva Systems (VEEV) Gains As Market Dips: What You Should Know - Yahoo Finance
Why Veeva Systems (VEEV) Stock Is Up Today - Yahoo Finance
Barclays Boosts Veeva Systems (NYSE:VEEV) Price Target to $275.00 - MarketBeat
Veeva Systems To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Monday - Sahm
Barclays Adjusts Price Target on Veeva Systems to $275 From $235, Keeps Overweight Rating - marketscreener.com
Veeva Systems(VEEV.US) Officer Sells US$9.01 Million in Common Stock - Moomoo
Veeva Systems (NYSE:VEEV) Insider Thomas Schwenger Sells 36,000 Shares of Stock - MarketBeat
Veeva Systems (NYSE: VEEV) exec sells 36K shares in preset plan - Stock Titan
VEEV Stock Is Surging Overnight: Michael Burry Says Incoming S&P 500 Entrant ‘Still Cheap’ - Stocktwits
VEEV Maintained by Oppenheimer -- Price Target Raised to $300 - GuruFocus
Veeva Systems (NYSE:VEEV) Stock Price Expected to Rise, Oppenheimer Analyst Says - MarketBeat
VEEV Maintained by Stifel -- Price Target Raised to $275 - GuruFocus
Oppenheimer Adjusts Veeva Systems PT to $300 From $225, Maintains Outperform Rating - marketscreener.com
Stifel raises Veeva Systems stock price target on growth outlook By Investing.com - Investing.com Canada
Stifel Adjusts Price Target on Veeva Systems to $275 From $230, Maintains Buy Rating - marketscreener.com
Veeva Systems Inc. (VEEV) Stock Analysis: Navigating the Healthcare Cloud with a $39.6 Billion Market Cap - DirectorsTalk Interviews
VEEVA SYSTEMS INC. : STIFEL RAISES TARGET PRICE TO $275 FROM $230 - Bitget
MAKENA CAPITAL MANAGEMENT LLC's Veeva Systems Inc(VEEV) Holding History - GuruFocus
BFSG, LLC's Veeva Systems Inc(VEEV) Holding History - GuruFocus
Can Veeva Systems Inc. (VEEV)’s AI Platform Keep Pace With Eli Lilly and Company (LLY)’s Explosive Growth - Yahoo Finance
Veeva Systems Falls 3.5% as Investors Weigh AI Timing and Post-Earnings Valuation - Quiver Quantitative
Mark Hillman's Top Q2 2026 Move: Veeva Systems Inc at a 1.8% Por - GuruFocus
Veeva upgraded at CFRA on integrating AI into its offerings - Seeking Alpha
10-Day Rally Sends Veeva Systems Stock Up 25% - Trefis
Handelsbanken Fonder AB Sells 30,650 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems Stock Climbs 25% On A 10-Day Winning Streak - Trefis
Veeva Systems Inc (VEEV) Stock Up 4.6% and Still Undervalued -- GF Score: 88/100 - GuruFocus
VEEV (NYSE: VEEV) insider files to sell 38,000 shares under Rule 144 - Stock Titan
Veeva : Modernizing Regulatory Operations with Automation and AI - marketscreener.com
Analysts Offer Insights on NA Companies: CoreWeave (CRWV), Veeva Systems (VEEV) and WEBTOON Entertainment Inc (WBTN) - The Globe and Mail
Veeva Systems (VEEV) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Veeva Systems Stock 8-Day Winning Spree: Stock Climbs 17% - Trefis
Truist Financial Maintains Veeva Systems(VEEV.US) With Buy Rating - Moomoo
Veeva Systems Inc Stock (VEEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):